TMS Co., Ltd. (TYO:4891)
Japan · Delayed Price · Currency is JPY 110.00
+1.00 (0.92%)
Aug 27, 2026, 3:30 PM JST
TMS Co., Ltd. Market Cap
TMS Co., Ltd. has a market cap or net worth of 4.98 billion as of August 26, 2026. Its market cap has decreased by -28.41% in one year.
Market Cap
4.98B
Enterprise Value
2.52B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
110.00
ChartMarket Cap Chart
Since November 22, 2022, TMS Co., Ltd.'s market cap has decreased from 28.10B to 4.98B, a decrease of -82.28%. That is a compound annual growth rate of -36.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 4.98B | -15.17% |
| Dec 30, 2025 | 5.87B | -33.26% |
| Dec 30, 2024 | 8.79B | 27.76% |
| Dec 29, 2023 | 6.88B | -69.65% |
| Dec 30, 2022 | 22.68B | -19.29% |
| Nov 22, 2022 | 28.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chiome Bioscience | 6.63B |
| Noile-Immune Biotech | 6.42B |
| PRISM BioLab Co.,LTD | 6.28B |
| Soiken Holdings | 5.86B |
| Chordia Therapeutics | 5.72B |
| Cyfuse Biomedical K.K. | 5.68B |
| D. Western Therapeutics Institute | 5.12B |
| J-Pharma | 4.93B |